Touchstone International Medical Science Co., Ltd. (SHA:688013)
China flag China · Delayed Price · Currency is CNY
21.78
-0.47 (-2.11%)
Nov 17, 2026, 3:00 PM CST

SHA:688013 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
255.91326.73272.34253.6231.73213.74
Other Revenue
000.030.040.310
255.91326.73272.37253.65232.03213.74
Revenue Growth
-18.53%19.96%7.38%9.31%8.56%30.85%
Cost of Revenue
97.54118.53113.64111.899.891.27
Gross Profit
158.37208.2158.73141.85132.23122.47
Selling, General & Admin
76.0881.374.6671.961.6662.37
Research & Development
57.0351.335.9935.3234.7529.28
Other Operating Expenses
2.41.861.794.752.392.13
Operating Expenses
136.35136.03112.38112.2798.9794.05
Operating Income
22.0372.1846.3429.5833.2728.41
Interest Expense
-0.23-0.47-0.23-0.09-0.16-
Interest & Investment Income
1.012.879.128.034.7611.15
Currency Exchange Gain (Loss)
10.6610.66-0.012.473.944
Other Non Operating Income (Expenses)
-18.02-0.2-0.171.89-0.12-0.06
EBT Excluding Unusual Items
15.4485.0355.0641.8841.6943.51
Gain (Loss) on Sale of Investments
15.848.48-1.894.062.090.44
Gain (Loss) on Sale of Assets
0.450.4-000.020.52
Asset Writedown
0.13-----
Legal Settlements
------1.08
Other Unusual Items
1.681.261.662.012.282.71
Pretax Income
33.5495.1754.8347.9546.0846.09
Income Tax Expense
3.799.982.940.642.894.67
Net Income
29.7585.1951.8947.3143.241.42
Net Income to Common
29.7585.1951.8947.3143.241.42
Net Income Growth
-63.32%64.15%9.69%9.53%4.29%18.52%
Shares Outstanding (Basic)
828080798080
Shares Outstanding (Diluted)
828181828281
Shares Change
1.46%0.05%-0.60%0.09%0.35%25.49%
EPS (Basic)
0.361.060.650.600.540.52
EPS (Diluted)
0.361.050.640.580.530.51
EPS Growth
-63.84%64.06%10.35%9.43%3.92%-5.56%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-47.61-18.7611.4764.542.7351.77
Free Cash Flow Per Share
-0.58-0.230.140.790.030.64
Dividend Per Share
0.8001.3001.000-0.2500.200
Dividend Growth
-20.00%30.00%--25.00%0%
Gross Margin
61.89%63.72%58.28%55.92%56.99%57.30%
Operating Margin
8.61%22.09%17.02%11.66%14.34%13.29%
Profit Margin
11.62%26.07%19.05%18.65%18.62%19.38%
Free Cash Flow Margin
-18.60%-5.74%4.21%25.44%1.18%24.22%
EBITDA
34.6583.5355.9938.6341.3535.64
EBITDA Margin
13.54%25.56%20.56%15.23%17.82%16.67%
D&A For EBITDA
12.6311.359.649.058.097.22
EBIT
22.0372.1846.3429.5833.2728.41
EBIT Margin
8.61%22.09%17.02%11.66%14.34%13.29%
Effective Tax Rate
11.31%10.49%5.36%1.33%6.27%10.14%
Revenue as Reported
82.9326.73272.37253.65232.03213.74